Pharmacy Research UK and the British Oncology Pharmacy Association (BOPA) are pleased to announce a new funding partnership for 2016. Grants will be awarded up to a value of £5,000 and may be used to support an independent research project or research component of a higher degree. Both pharmacists and pharmacy technicians are eligible to apply for funds for projects in translational and health service research related to oncology and haematology pharmacy.
Further details with scheme guidance available online from February 1st.
The Research Awards will support projects in translational and health service research related to oncology and haematology pharmacy with a focus on patient benefit and provide a platform for novice researchers to engage in research. Through these awards PRUK and BOPA aim to build the capacity for research within oncology and haematology pharmacy, provide evidence to inform healthcare policy and to highlight the vital role of pharmacists and pharmacy technicians in the wider healthcare community.
Dr Rachel Joynes, Head of Research and Evaluation at Pharmacy Research UK said ‘we are delighted to be announcing this new partnership with BOPA which we hope will not only allow both pharmacists and pharmacy technicians to undertake research but also presents an opportunity for those new to research to lead their first project’.
Carl Booth, Chair of the BOPA Audit and Research Sub-Committee notes ‘BOPA is incredibly excited to be funding our first research projects to build the base of evidence in oncology and haematology pharmacy. We hope this funding will allow our members to explore previously unanswered questions and will support the development of new skills and future opportunities’.
Successful applicants will be invited to present their work at the BOPA annual symposium in 2017.
Applications will open in February 2016, with a deadline of May 2016. Register your interest below. Further details are available: http://www.pharmacyresearchuk.org with scheme guidance available online from February 1st.